AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹171 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹171 Cr |
| Mar2024 | ₹166 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹141 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹171 Cr | 3.07 | |
| Mar2024 | ₹166 Cr | -18.89 | |
| Mar2023 | ₹205 Cr | -26.88 | |
| Mar2022 | ₹280 Cr | 98.31 | |
| Mar2021 | ₹141 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,222.9 Cr | -0.7% | -0.2% | 6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.7% |
-0.2% |
6.6% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses